Molecular genetics of lung cancer in people who have never smoked - PubMed (original) (raw)
Review
Molecular genetics of lung cancer in people who have never smoked
Janakiraman Subramanian et al. Lancet Oncol. 2008 Jul.
Abstract
Lung cancer is a major cause of cancer-related mortality in the USA, and tobacco smoke is the major risk factor for this disease. However, many patients with lung cancer have never smoked (never smokers). Patients with lung cancer who have never smoked are more likely to have mutations in epidermal growth factor receptor (EGFR) tyrosine kinase and have better response to its inhibitors than do patients with tobacco-associated lung cancer. Furthermore, the prevalences of mutations in KRAS and P53 differ for patients with lung cancer who have never smoked and those with tobacco-associated lung cancer. Genetic mutations seem to be more common in patients with tobacco-associated lung cancer than in never smokers. Current evidence indicates that the two types of lung cancer are biologically distinct. Here, we review published studies of the molecular genetics of lung cancer in never smokers and identify the specific differences from tobacco-associated lung cancer.
Similar articles
- Lung cancer in never smokers: a review.
Subramanian J, Govindan R. Subramanian J, et al. J Clin Oncol. 2007 Feb 10;25(5):561-70. doi: 10.1200/JCO.2006.06.8015. J Clin Oncol. 2007. PMID: 17290066 Review. - TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
Le Calvez F, Mukeria A, Hunt JD, Kelm O, Hung RJ, Tanière P, Brennan P, Boffetta P, Zaridze DG, Hainaut P. Le Calvez F, et al. Cancer Res. 2005 Jun 15;65(12):5076-83. doi: 10.1158/0008-5472.CAN-05-0551. Cancer Res. 2005. PMID: 15958551 - p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.
Husgafvel-Pursiainen K, Boffetta P, Kannio A, Nyberg F, Pershagen G, Mukeria A, Constantinescu V, Fortes C, Benhamou S. Husgafvel-Pursiainen K, et al. Cancer Res. 2000 Jun 1;60(11):2906-11. Cancer Res. 2000. PMID: 10850436 - Lung cancer in never smokers.
Torok S, Hegedus B, Laszlo V, Hoda MA, Ghanim B, Berger W, Klepetko W, Dome B, Ostoros G. Torok S, et al. Future Oncol. 2011 Oct;7(10):1195-211. doi: 10.2217/fon.11.100. Future Oncol. 2011. PMID: 21992731 Review. - Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.
Pham D, Kris MG, Riely GJ, Sarkaria IS, McDonough T, Chuai S, Venkatraman ES, Miller VA, Ladanyi M, Pao W, Wilson RK, Singh B, Rusch VW. Pham D, et al. J Clin Oncol. 2006 Apr 10;24(11):1700-4. doi: 10.1200/JCO.2005.04.3224. Epub 2006 Feb 27. J Clin Oncol. 2006. PMID: 16505411
Cited by
- Genomic landscape of lung adenocarcinomas in different races.
Shi H, Seegobin K, Heng F, Zhou K, Chen R, Qin H, Manochakian R, Zhao Y, Lou Y. Shi H, et al. Front Oncol. 2022 Sep 28;12:946625. doi: 10.3389/fonc.2022.946625. eCollection 2022. Front Oncol. 2022. PMID: 36248982 Free PMC article. - Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer.
Isa SI, Kurahara Y, Yamamoto S, Tamiya A, Omachi N, Asami K, Okishio K, Utsumi T, Ito N, Yoon HE, Matsumura A, Atagi S, Kawaguchi T. Isa SI, et al. Oncol Lett. 2015 Feb;9(2):927-929. doi: 10.3892/ol.2014.2713. Epub 2014 Nov 19. Oncol Lett. 2015. PMID: 25621070 Free PMC article. - EGFR-mutated lung cancer: a paradigm of molecular oncology.
Zhang Z, Stiegler AL, Boggon TJ, Kobayashi S, Halmos B. Zhang Z, et al. Oncotarget. 2010 Nov;1(7):497-514. doi: 10.18632/oncotarget.186. Oncotarget. 2010. PMID: 21165163 Free PMC article. Review. - Smoking Status and Survival Among a National Cohort of Lung and Colorectal Cancer Patients.
Japuntich SJ, Kumar P, Pendergast JF, Juarez Caballero GY, Malin JL, Wallace RB, Chrischilles EA, Keating NL, Park ER. Japuntich SJ, et al. Nicotine Tob Res. 2019 Mar 30;21(4):497-504. doi: 10.1093/ntr/nty012. Nicotine Tob Res. 2019. PMID: 29351659 Free PMC article. - TP53 mutations in nonsmall cell lung cancer.
Mogi A, Kuwano H. Mogi A, et al. J Biomed Biotechnol. 2011;2011:583929. doi: 10.1155/2011/583929. Epub 2011 Jan 18. J Biomed Biotechnol. 2011. PMID: 21331359 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous